Related Experiment Videos
Mitochondria and HIV infection: the first decade
A Cossarizza1, L Troiano, C Mussini
1Department of Biomedical Sciences, University of Modena and Reggio Emilia School of Medicine, Italy. cossariz@unimo.it
Summary
Human immunodeficiency virus (HIV) infection and its treatment can damage mitochondria. This review examines the critical role of mitochondria in HIV pathogenesis and treatment side effects like lipodystrophy.
Area of Science:
- Mitochondrial biology
- Virology
- Immunology
Background:
- Mitochondrial damage is observed in human immunodeficiency virus (HIV) infection.
- Highly active antiretroviral therapy (HAART) can cause mitochondrial damage and lipodystrophy.
- The exact mechanisms and HAART's role in lipodystrophy are under investigation.
Purpose of the Study:
- To review the interactions between mitochondria and HIV infection.
- To explore the role of mitochondria in HIV pathogenesis.
- To discuss mitochondrial dysfunction in HAART-induced lipodystrophy.
Main Methods:
- Literature review of studies on HIV, mitochondria, and antiretroviral therapy.
- Analysis of data on mitochondrial damage in HIV patients.
- Examination of mechanisms underlying HAART-induced mitochondrial dysfunction.
Main Results:
- HIV infection impacts mitochondrial function.
- HAART, including protease inhibitors and nucleoside-analogue reverse-transcriptase inhibitors, can induce mitochondrial damage.
- Mitochondrial DNA (mtDNA) damage is hypothesized to be a key factor in HAART-induced lipodystrophy.
Conclusions:
- Mitochondria play a crucial role in HIV pathogenesis.
- Mitochondrial dysfunction is implicated in the side effects of antiretroviral therapy.
- Further research is needed to elucidate the precise mechanisms of drug-induced mitochondrial damage and lipodystrophy.